In the latest episode of our monthly podcast, the team discusses their early memories of covering IP before delving into the latest on the UPC and whether a proposed US study could threaten the future of pharma patents
Company size and market forces may explain why less than a third of patents have been opted out in both telecoms and medical technology, according to sources